A Case of Aplasia Cutis Congenita in the Setting of Maternal Carbimazole Use in the First Trimester.
Issue Date
2023-11-16Keywords
Graves’ diseaseCarbimazole
cutis aplasia
Hyperthyroidism
Metadata
Show full item recordJournal
JCEM case reportsDOI
10.1210/jcemcr/luad130PubMed ID
38021077PubMed Central ID
PMC10652245Item Type
OtherLanguage
enEISSN
2755-1520ae974a485f413a2113503eed53cd6c53
10.1210/jcemcr/luad130
Scopus Count
Related articles
- [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
- Authors: Sachs C, Tebacher-Alt M, Mark M, Cribier B, Lipsker D
- Issue date: 2016 Jun-Jul
- Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
- Authors: Andersen SL, Olsen J, Wu CS, Laurberg P
- Issue date: 2013 Nov
- Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
- Authors: Yoshihara A, Noh J, Yamaguchi T, Ohye H, Sato S, Sekiya K, Kosuga Y, Suzuki M, Matsumoto M, Kunii Y, Watanabe N, Mukasa K, Ito K, Ito K
- Issue date: 2012 Jul
- Carbimazole embryopathy in a Chinese population: case series and literature review.
- Authors: Ting YH, Zhou Y, Lao TT
- Issue date: 2013 Apr
- Grade 1 microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in methimazole embryopathy.
- Authors: Gripp KW, Kuryan R, Schnur RE, Kothawala M, Davey LR, Antunes MJ, Reichard KW, Schneider A, Hall BD
- Issue date: 2011 Mar